Article
Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.
PloS one - 1 Jan 2016
King Audrey J, Sonsma Jan A, Vriend Henrike J, van der Sande Marianne A B, Feltkamp Mariet C, Boot Hein J, Koopmans Marion P G
Abstract excerpt
OBJECTIVES: Intratypic molecular variants of human papillomavirus (HPV) type-16 and -18 exist. In the Netherlands, a bivalent vaccine, composed of recombinant L1 proteins from HPV-16 and -18, is used to prevent cervical cancer since 2009. Long-term vaccination could lead to changes in HPV-16 and -18 virus population, thereby hampering vaccination strategies. We determined the genetic diversity of the L1 gene in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
